Loading…
Held by equity mutual funds in 5 disclosed months, May 2026 to Sep 2026.
Gujarat Themis Biosyn Limited (Pharmaceuticals & Biotechnology) was held by 7 active equity mutual funds in September 2026, ₹313 Cr in all (up 1 fund from Aug 2026). The largest position was Samco Active Momentum Fund at 1.4% of its portfolio. During the month 1 fund entered and 0 exited. Funds have disclosed holding it since May 2026.
Weight is the share of that fund's portfolio; change is against the previous disclosed month.
None.
None.
How many equity funds held the company each month, and the value they held.